Literature DB >> 23765236

The ETHICA study (part I): elderly's thoughts about intensive care unit admission for life-sustaining treatments.

F Philippart1, A Vesin, C Bruel, A Kpodji, B Durand-Gasselin, P Garçon, M Levy-Soussan, J L Jagot, N Calvo-Verjat, J F Timsit, B Misset, M Garrouste-Orgeas.   

Abstract

PURPOSE: To assess preferences among individuals aged ≥80 years for a future hypothetical critical illness requiring life-sustaining treatments.
METHODS: Observational cohort study of consecutive community-dwelling elderly individuals previously hospitalised in medical or surgical wards and of volunteers residing in nursing homes or assisted-living facilities. The participants were interviewed at their place of residence after viewing films of scenarios involving the use of non-invasive mechanical ventilation (NIV), invasive mechanical ventilation (IMV), and renal replacement therapy after a period of invasive mechanical ventilation (RRT after IMV). Demographic, clinical, and quality-of-life data were collected. Participants chose among four responses regarding life-sustaining treatments: consent, refusal, no opinion, and letting the physicians decide.
RESULTS: The sample size was 115 and the response rate 87 %. Mean participant age was 84.8 ± 3.5 years, 68 % were female, and 81 % and 71 % were independent for instrumental activities and activities of daily living, respectively. Refusal rates among the elderly were 27 % for NIV, 43 % for IMV, and 63 % for RRT (after IMV). Demographic characteristics associated with refusal were married status for NIV [relative risk (RR), 2.9; 95 % confidence interval (95 %CI), 1.5-5.8; p = 0.002] and female gender for IMV (RR, 2.4; 95 %CI, 1.2-4.5; p = 0.01) and RRT (after IMV) (RR, 2.7; 95 %CI, 1.4-5.2; p = 0.004). Quality of life was associated with choices regarding all three life-sustaining treatments.
CONCLUSIONS: Independent elderly individuals were rather reluctant to accept life-sustaining treatments, especially IMV and RRT (after IMV). Their quality of life was among the determinants of their choices.

Entities:  

Mesh:

Year:  2013        PMID: 23765236     DOI: 10.1007/s00134-013-2976-y

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  37 in total

1.  Time for a change.

Authors:  Angela Coulter
Journal:  Health Expect       Date:  2007-09       Impact factor: 3.377

2.  Influence of an advance directive on the initiation of life support technology in critically ill cancer patients.

Authors:  S Kish Wallace; C G Martin; A D Shaw; K J Price
Journal:  Crit Care Med       Date:  2001-12       Impact factor: 7.598

3.  Odds ratio or relative risk for cross-sectional data?

Authors:  J Lee
Journal:  Int J Epidemiol       Date:  1994-02       Impact factor: 7.196

4.  Cardiopulmonary resuscitation preferences in Dutch community-dwelling and hospitalized elderly people: an interaction between gender and quality of life.

Authors:  A H van Mil; R C van Klink; C Huntjens; R G Westendorp; A M Stiggelbout; A E Meinders; A M Lagaay
Journal:  Med Decis Making       Date:  2000 Oct-Dec       Impact factor: 2.583

Review 5.  Patients' preference for involvement in medical decision making: a narrative review.

Authors:  Rebecca Say; Madeleine Murtagh; Richard Thomson
Journal:  Patient Educ Couns       Date:  2006-02

Review 6.  Patient preferences for shared decisions: a systematic review.

Authors:  Betty Chewning; Carma L Bylund; Bupendra Shah; Neeraj K Arora; Jennifer A Gueguen; Gregory Makoul
Journal:  Patient Educ Couns       Date:  2011-04-06

7.  Advance directives in the medical intensive care unit of a community teaching hospital.

Authors:  R F Johnson; T Baranowski-Birkmeier; J B O'Donnell
Journal:  Chest       Date:  1995-03       Impact factor: 9.410

8.  Choices of seriously ill patients about cardiopulmonary resuscitation: correlates and outcomes. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.

Authors:  R S Phillips; N S Wenger; J Teno; R K Oye; S Youngner; R Califf; P Layde; N Desbiens; A F Connors; J Lynn
Journal:  Am J Med       Date:  1996-02       Impact factor: 4.965

9.  Selection of intensive care unit admission criteria for patients aged 80 years and over and compliance of emergency and intensive care unit physicians with the selected criteria: An observational, multicenter, prospective study.

Authors:  Maité Garrouste-Orgeas; Ariane Boumendil; Dominique Pateron; Philippe Aergerter; Dominique Somme; Tabassome Simon; Bertrand Guidet
Journal:  Crit Care Med       Date:  2009-11       Impact factor: 7.598

10.  Quality of life in patients aged 80 or over after ICU discharge.

Authors:  Alexis Tabah; Francois Philippart; Jean Francois Timsit; Vincent Willems; Adrien Français; Alain Leplège; Jean Carlet; Cédric Bruel; Benoit Misset; Maité Garrouste-Orgeas
Journal:  Crit Care       Date:  2010-01-08       Impact factor: 9.097

View more
  31 in total

1.  "Are you sure it's about 'age'?".

Authors:  Katerina Rusinova; Bertrand Guidet
Journal:  Intensive Care Med       Date:  2013-11-12       Impact factor: 17.440

2.  Healthcare-related costs in very elderly intensive care patients.

Authors:  L E M Haas; Ilse van Beusekom; Diederik van Dijk; Marije E Hamaker; Ferishta Bakhshi-Raiez; Dylan W de Lange; Nicolette F de Keizer
Journal:  Intensive Care Med       Date:  2018-09-25       Impact factor: 17.440

3.  Examining mechanisms for gender differences in admission to intensive care units.

Authors:  Andrea Hill; Clare Ramsey; Peter Dodek; Jean Kozek; Randy Fransoo; Robert Fowler; Malcolm Doupe; Hubert Wong; Damon Scales; Allan Garland
Journal:  Health Serv Res       Date:  2019-11-10       Impact factor: 3.402

4.  Selection and Receipt of Kidney Replacement in Critically Ill Older Patients with AKI.

Authors:  Sean M Bagshaw; Neill K J Adhikari; Karen E A Burns; Jan O Friedrich; Josée Bouchard; Francois Lamontagne; Lauralyn A McIntrye; Jean-François Cailhier; Peter Dodek; Henry T Stelfox; Margaret Herridge; Stephen Lapinsky; John Muscedere; James Barton; Donald Griesdale; Mark Soth; Althea Ambosta; Gerald Lebovic; Ron Wald
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-21       Impact factor: 8.237

5.  Year in review in Intensive Care Medicine 2013: II. Sedation, invasive and noninvasive ventilation, airways, ARDS, ECMO, family satisfaction, end-of-life care, organ donation, informed consent, safety, hematological issues in critically ill patients.

Authors:  Elie Azoulay; Giuseppe Citerio; Jan Bakker; Matteo Bassetti; Dominique Benoit; Maurizio Cecconi; J Randall Curtis; Glenn Hernandez; Margaret Herridge; Samir Jaber; Michael Joannidis; Laurent Papazian; Mark Peters; Pierre Singer; Martin Smith; Marcio Soares; Antoni Torres; Antoine Vieillard-Baron; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2014-01-24       Impact factor: 17.440

6.  Ten things to know about critically ill elderly patients.

Authors:  Guillaume Leblanc; Ariane Boumendil; Bertrand Guidet
Journal:  Intensive Care Med       Date:  2016-08-04       Impact factor: 17.440

7.  Should this elderly patient be admitted to the ICU?

Authors:  Bertrand Guidet; Dylan W de Lange; Hans Flaatten
Journal:  Intensive Care Med       Date:  2018-01-22       Impact factor: 17.440

8.  The ETHICA study (part II): simulation study of determinants and variability of ICU physician decisions in patients aged 80 or over.

Authors:  M Garrouste-Orgeas; A Tabah; A Vesin; F Philippart; A Kpodji; C Bruel; C Grégoire; A Max; J F Timsit; B Misset
Journal:  Intensive Care Med       Date:  2013-06-14       Impact factor: 17.440

9.  The impact of patient preferences on physician decisions in the ICU: still much to learn.

Authors:  William J Ehlenbach
Journal:  Intensive Care Med       Date:  2013-06-14       Impact factor: 17.440

10.  The Validity of Advance Directives in Acute Situations.

Authors:  Nadja Leder; Daniel Schwarzkopf; Konrad Reinhart; Otto W Witte; Rüüdiger Pfeifer; Christiane S Hartog
Journal:  Dtsch Arztebl Int       Date:  2015-10-23       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.